Purpura, Thrombocytopenic
Showing 1 - 25 of 1,066
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023
Purpura, Thrombocytopenic Trial in Sevilla (Standard clinical practice)
Not yet recruiting
- Purpura, Thrombocytopenic
- Standard clinical practice
-
Sevilla, Andalucia, SpainHospital Universitario Virgen del Rocío
Jun 13, 2023
TTP - Thrombotic Thrombocytopenic Purpura Trial in Ankara
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
-
Ankara, TurkeyBaskent Universtiy Faculty of Medicine
Jul 15, 2023
Immune Thrombocytopenic Purpura Trial in Sohag (serum interleukin 10 level)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- serum interleukin 10 level
-
Sohag, EgyptSohag University Hospital
Apr 18, 2023
Caplacizumab in Treatment of Acquired Thrombotic
Not yet recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
-
Cologne, GermanyUniversity Hospital of Cologne
May 25, 2023
Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)
Completed
- Idiopathic Thrombocytopenic Purpura
- Placebo
- AMG 531
- (no location specified)
Nov 4, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
No longer available
- Thrombotic Thrombocytopenic Purpura (TTP)
- (no location specified)
Mar 3, 2023
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- +2 more
- Romiplostim
- (no location specified)
Nov 10, 2022
COVID-19 Vaccine and Development of Immune Thrombocytopenic
Recruiting
- COVID-19 Vaccine
- covid19 vaccines
-
Assiut, EgyptEgypt
Jul 12, 2022
Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic
Active, not recruiting
- Immune-mediated Thrombocytopenic Purpura
-
Chilly-Mazarin, FranceSanofi-Aventis
Aug 8, 2022
Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Genotyping of rs1883832C/T related single-nucleotide polymorphism
-
Sohag, EgyptSohag University hospitals
Oct 16, 2022
Construction of a Database for TTP
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
- collection data
-
Suzhou, Jiangsu, Chinathe first affiliated hospital of Soochow university
Oct 5, 2022
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- TAK-755
- (no location specified)
Feb 9, 2023
Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Aspirin tablet
- Placebo
- (no location specified)
Sep 30, 2022
Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)
Active, not recruiting
- Idiopathic Thrombocytopenic Purpura
- R788
- Placebo
-
Multiple Locations, JapanResearch Site
Mar 22, 2022
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
Recruiting
- Thrombotic Thrombocytopenic Purpura
-
Mainz, GermanyUniversity Hospital Mainz, Hematology
May 20, 2022
Idiopathic Thrombocytopenic Purpura Trial in Wuhan, Chengdu, Tianjin (Hetrombopag Olamine, matching )
Completed
- Idiopathic Thrombocytopenic Purpura
- Hetrombopag Olamine
- matching placebo
-
Wuhan, Hubei, China
- +2 more
Aug 2, 2022
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment
Completed
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab (ALX-0081)
- +3 more
-
Iruma-Gun, Japan
- +11 more
Jan 30, 2023
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023